VERTEX PHARMACEUTICALS INC / MA Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 551,600 | |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 38,200 | |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 24,188 | |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 121.67 | 400 | 48,668 | 338,895 | 339.3 K to 338.9 K (-0.12 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 120.78 | 600 | 72,468 | 339,295 | 339.9 K to 339.3 K (-0.18 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 119.33 | 500 | 59,665 | 339,895 | 340.4 K to 339.9 K (-0.15 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 118.22 | 900 | 106,398 | 340,395 | 341.3 K to 340.4 K (-0.26 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 117.44 | 4,570 | 536,701 | 341,295 | 345.9 K to 341.3 K (-1.32 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 116.56 | 3,530 | 411,457 | 345,865 | 349.4 K to 345.9 K (-1.01 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Dec 23 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 556,000 | |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 39,500 | |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 28,988 | |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.05 | 1,700 | 190,485 | 338,895 | 340.6 K to 338.9 K (-0.50 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 111.13 | 2,800 | 311,164 | 340,595 | 343.4 K to 340.6 K (-0.82 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 110.04 | 6,000 | 660,240 | 343,395 | 349.4 K to 343.4 K (-1.72 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Dec 19 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 120.17 | 200 | 24,034 | 217,677 | 217.9 K to 217.7 K (-0.09 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 119.00 | 200 | 23,800 | 217,877 | 218.1 K to 217.9 K (-0.09 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 118.05 | 2,700 | 318,735 | 218,077 | 220.8 K to 218.1 K (-1.22 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 117.26 | 8,650 | 1,014,299 | 220,777 | 229.4 K to 220.8 K (-3.77 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 116.27 | 3,400 | 395,318 | 229,427 | 232.8 K to 229.4 K (-1.46 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 115.05 | 6,406 | 737,010 | 232,827 | 239.2 K to 232.8 K (-2.68 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 114.21 | 15,440 | 1,763,402 | 239,233 | 254.7 K to 239.2 K (-6.06 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 113.19 | 13,021 | 1,473,847 | 254,673 | 267.7 K to 254.7 K (-4.86 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Gift | G | 0.00 | 2,500 | 0 | 267,694 | 270.2 K to 267.7 K (-0.93 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 120.44 | 2,880 | 346,867 | 113,826 | 116.7 K to 113.8 K (-2.47 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 119.82 | 3,162 | 378,871 | 116,706 | 119.9 K to 116.7 K (-2.64 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 120.48 | 1,100 | 132,528 | 14,187 | 15.3 K to 14.2 K (-7.20 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 119.82 | 1,713 | 205,252 | 15,287 | 17 K to 15.3 K (-10.08 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 120.50 | 220 | 26,510 | 34,375 | 34.6 K to 34.4 K (-0.64 %) |
Dec 16 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 119.73 | 300 | 35,919 | 34,595 | 34.9 K to 34.6 K (-0.86 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.01 | 125,000 | 1,250 | 270,194 | 145.2 K to 270.2 K (+86.09 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 560,400 | |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 40,800 | |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 33,788 | |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 121.32 | 900 | 109,188 | 338,895 | 339.8 K to 338.9 K (-0.26 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 120.32 | 3,400 | 409,088 | 339,795 | 343.2 K to 339.8 K (-0.99 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 119.57 | 2,900 | 346,753 | 343,195 | 346.1 K to 343.2 K (-0.84 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 118.49 | 1,400 | 165,886 | 346,095 | 347.5 K to 346.1 K (-0.40 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 117.45 | 1,900 | 223,155 | 347,495 | 349.4 K to 347.5 K (-0.54 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Dec 12 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Option Exercise | M | 53.74 | 937 | 50,354 | 6,563 | |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 120.62 | 100 | 12,062 | 34,895 | 35 K to 34.9 K (-0.29 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 119.36 | 337 | 40,224 | 34,995 | 35.3 K to 35 K (-0.95 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 118.40 | 500 | 59,200 | 35,332 | 35.8 K to 35.3 K (-1.40 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Buy | M | 53.74 | 937 | 50,354 | 35,832 | 34.9 K to 35.8 K (+2.69 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 564,800 | |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 42,100 | |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 38,588 | |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 120.45 | 200 | 24,090 | 338,895 | 339.1 K to 338.9 K (-0.06 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 119.82 | 10,300 | 1,234,146 | 339,095 | 349.4 K to 339.1 K (-2.95 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Dec 05 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 77.31 | 3,867 | 298,958 | 16,758 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 83.36 | 4,297 | 358,198 | 9,453 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 119.85 | 8,164 | 978,455 | 17,000 | 25.2 K to 17 K (-32.44 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 77.31 | 3,867 | 298,958 | 25,164 | 21.3 K to 25.2 K (+18.16 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 83.36 | 4,297 | 358,198 | 21,297 | 17 K to 21.3 K (+25.28 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 28.40 | 10,000 | 284,000 | 10,000 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 120.03 | 10,000 | 1,200,300 | 21,210 | 31.2 K to 21.2 K (-32.04 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 28.40 | 10,000 | 284,000 | 31,210 | 21.2 K to 31.2 K (+47.15 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | M | 39.05 | 12,000 | 468,600 | 17,375 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 120.00 | 12,000 | 1,440,000 | 78,671 | 90.7 K to 78.7 K (-13.23 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Buy | M | 39.05 | 12,000 | 468,600 | 90,671 | 78.7 K to 90.7 K (+15.25 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Option Exercise | M | 59.55 | 2,500 | 148,875 | 0 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Option Exercise | M | 63.14 | 1,000 | 63,140 | 15,000 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Sell | S | 119.75 | 3,500 | 419,125 | 0 | 3.5 K to 0 (-100.00 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Buy | M | 59.55 | 2,500 | 148,875 | 3,500 | 1,000 to 3.5 K (+250.00 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Buy | M | 63.14 | 1,000 | 63,140 | 1,000 | 0 to 1,000 |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 569,200 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 43,400 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 43,388 | |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 115.28 | 1,449 | 167,041 | 338,895 | 340.3 K to 338.9 K (-0.43 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 114.42 | 9,051 | 1,035,615 | 340,344 | 349.4 K to 340.3 K (-2.59 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Dec 01 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |